ICD 10 CM M08.059 | Description & Clinical Information

ICD 10 M08.059 describes a medical condition known as juvenile arthritis, which is a group of inflammatory autoimmune joint disorders that affect children who are 16 years old or younger, and can also impact other parts of the body such as connective tissues, eyes, skin, spine, and digestive systems, however, in this particular case, the provider has not specified the exact type of juvenile rheumatoid arthritis that involves the hip, nor has he documented whether it affects the right or left hip.

Official Description Of M08.059

The ICD 10 CM book defines ICD 10 code M08.059 as:

Unspecified juvenile rheumatoid arthritis, unspecified hip
Parent Code Notes: M08

Excludes1: arthropathy in Whipple’s disease (M14.8)
Felty’s syndrome (M05.0)
juvenile dermatomyositis (M33.0-)
psoriatic juvenile arthropathy (L40.54)

Code also: any associated underlying condition, such as:
regional enteritis [Crohn’s disease] (K50.-)
ulcerative colitis (K51.-)

When To Use M08.059

The diagnosis described by ICD 10 CM M08.059 pertains to unspecified juvenile arthritis of an unspecified hip. Juvenile arthritis affects children under the age of 16, and it represents one of the most common chronic illnesses affecting kids in the US. The condition leads to joint pain, deformity, swelling, warmth, redness, and morning stiffness. However, it can also result in systemic symptoms, such as skin rash, high fever, or lymph node enlargement.

The causes of juvenile arthritis are still unclear, but some factors may lead to the development of the condition, including genetics and environmental triggers such as infections. The diagnosis of juvenile arthritis is based on the patient’s history and physical examination. Medical professionals assess the symptoms and underlying causes to determine the most appropriate treatment approach.

In addition to a physical examination, medical professionals may request blood tests to check for the presence of rheumatoid factor or other antibodies that may indicate an autoimmune condition. Providers may also use laboratory exams to test for inflammatory markers, such as C-reactive protein and erythrocyte sedimentation rate. Analyses of synovial fluid may also be necessary to rule out other potential causes of joint pain or inflammation.

There are many different types of juvenile arthritis, some of which affect one joint, while others affect multiple. It is therefore essential for medical professionals to determine the specific type of arthritis, which can help to guide the most effective treatment options.

One critical aspect of treating juvenile arthritis is to stay active, and various exercises can be beneficial. Walking, bicycling, and swimming, can help with movement and flexibility, and potentially reduce pain and stiffness. Physical therapy and occupational therapy may also be helpful in treating juvenile arthritis.

The appropriate medication regimen will depend on the type of juvenile arthritis the child has and the severity of the disease. Nonsteroidal anti-inflammatory drugs are commonly used as first-line therapy to reduce pain and inflammation. If NSAIDs are not sufficient, corticosteroids or disease-modifying antirheumatic drugs may be prescribed. In some cases, biologic response modifiers may be necessary.

While juvenile arthritis can cause significant pain and mobility problems, proper diagnosis and treatment can help children manage their symptoms and lead active, healthy lives. It is essential for medical professionals to diagnose the condition promptly and develop individualized treatment plans tailored to each patient. By working together with parents and children, medical professionals can improve outcomes and quality of life for children living with juvenile arthritis.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *